SESSION 1 SCHEDULE
Wednesday
SESSION 1: HEMODIALYSIS ACCESS - PART 1
Moderators:TBD
x
7:50 AM - 7:59 AM Introduction
 
PART 1A: ACCESS PLANNING, DYSFUNCTIONAL FISTULAS AND CENTRAL VENOUS CATHETERS
Moderator(s): TBD  
8:00 AM - 8:10 AM Results Of The Dialysis Access Consortium: Where Do We Go From Here?
 
8:11 AM - 8:21 AM Does Physical Examination Have A Role In The Planning And Evaluation Of Hemodialysis Access?
 
8:22 AM - 8:32 AM Update On Ultrasound Imaging For Hemodialysis Access
 
8:33 AM - 8:43 AM Fundamentals Of Angiographic Evaluation Of AV Access
 
8:44 AM - 8:54 AM Facilitating Endovascular Access Procedures Using Flouro Trace
 
8:55 AM - 9:05 AM Management Of The Immature Fistula
 
9:06 AM - 9:16 AM Salvaging The Unsalvageable Fistula
 
9:17 AM - 9:27 AM Dialysis Catheters Are Bad News
 
9:28 AM - 9:38 AM Catheters Don’t Kill Patients
 
9:39 AM - 9:59 AM Panel Discussion
10:00 AM - 10:20 AM Break / Visit Exhibits
PART 1B: MANAGEMENT OF CENTRAL VENOUS PROBLEMS
Moderator(s): TBD / TBD  
10:21 AM - 10:31 AM Pathophysiology Of Fibrin Sheath Development
 
10:32 AM - 10:42 AM Removal Of Embedded Catheters
 
10:43 AM - 10:53 AM Catheter Exchange Procedures
 
10:54 AM - 11:04 AM Catheter-Related Central Venous Stenosis
 
11:05 AM - 11:15 AM Pacemaker/Defibrillator Related Central Venous Stenosis
 
11:16 AM - 11:26 AM Power Wire For Central Venous Stenoses
 
11:27 AM - 11:37 AM Use Of The Peripheral Cutting Balloon For Treatment Of Cephalic Arch Stenosis Associated With Brachiocephalic Fistulas
 
11:38 AM - 11:48 AM Fatal Complications Of SVC Angioplasty
 
11:49 AM - 12:10 PM Panel Discussion
12:10 PM - 1:05 PM Lunch Break / Visit Exhibits
END OF SESSION 1
 
SESSION 2 SCHEDULE
Wednesday
SESSION 2: HEMODIALYSIS ACCESS - PART 2
Moderators:TBD
x
PART 2A: HEMODIALYSIS ACCESS COMPLICATIONS / THROMBECTOMY PROCEDURES
Moderator(s): TBD / TBD  
1:05 PM - 1:15 PM Surgical vs. Percutaneous Thrombectomy: Which Is Best?
 
1:16 PM - 1:26 PM Techniques For Percutaneous Thrombectomy
 
1:27 PM - 1:37 PM Management Of Arterial Embolization During Percutaneous Thrombectomy Of Hemodialysis Grafts And Fistulas
 
1:38 PM - 1:43 PM Debate: Should Interventionalists Do Surgery: Pro
 
1:44 PM - 1:49 PM Debate: Should Interventionalists Do Surgery: Con
 
1:50 PM - 2:00 PM Vascular Access Hemorrhagic Deaths Among Hemodialysis Patients
 
2:01 PM - 2:11 PM Are Antiplatelet Drugs Or Anticoagulation Ever Indicated To Maintain Access Patency?
 
2:12 PM - 2:32 PM Panel Discussion
2:33 PM - 2:55 PM Break / Visit Exhibits
PART 2B: UPDATE ON NEW TECHNOLOGIES (5 MINUTE TALKS)
Moderator(s): TBD / TBD  
2:56 PM - 3:01 PM Topical rThrombin For Wound Hemostasis
 
3:02 PM - 3:07 PM Role Of Heparin Bonded ePTFE Grafts In Dialysis Access
 
3:08 PM - 3:13 PM Preliminary Experience With The Duraspan Hemodialysis Catheter
 
3:14 PM - 3:19 PM Recombinant Human Elastase For Improved Vascular Access
 
3:20 PM - 3:30 PM Panel Discussion
PART 2C: IMPORTANT TOPICS IN VASCULAR ACCESS
Moderator(s): TBD / TBD  
3:31 PM - 3:41 PM Optimizing Hemodialysis Cannulation Methods: Role Of Buttonhole Cannulation
 
3:42 PM - 3:52 PM Clinical Practice Guidelines For Hemodialysis Access
 
3:53 PM - 4:03 PM Reimbursement For Vascular Access: What Does The Future Hold?
 
4:04 PM - 4:14 PM Vascular Access Surveillance And The CMS MAT-V551 Requirement
 
4:15 PM - 4:25 PM Radial-to-Cephalic Arteriovenous Fistulas As A Method Of Choice In Children And Adolescents
 
4:26 PM - 4:36 PM Perfect Dialysis Access Graft: Are We There Yet?
 
4:37 PM - 4:47 PM Ischemic Monomelic Neuropathy
 
4:48 PM - 5:10 PM Panel Discussion
5:10 PM - 5:10 PM Adjourn
END OF SESSION 2
 
SESSION 3 SCHEDULE
Wednesday
SESSION 3: NEW HORIZONS IN CARDIOVASCULAR SURGERY: MANAGEMENT OF AORTIC DISEASE - PART 1
Moderators: / TBD
x
12:30 PM - 12:40 PM Opening Remarks
 
12:40 PM - 1:40 PM Case Studies: Clinical Presentation
  Presenters(s):Hazim J. Safi, MD  
1:40 PM - 1:55 PM What Imaging Won’t Tell Us About Aortic Disease
 
1:55 PM - 2:10 PM Genetic Disorders: Implications And Testing Efforts
 
2:10 PM - 2:25 PM Proximal Dissections: Acute Treatment Objectives And Long-Term Results
 
2:25 PM - 2:40 PM Surgical Education In The Era Of Rapidly Developing New Technologies
 
2:40 PM - 2:55 PM Pure Endovascular TAA Repair Techniques And Future
 
2:55 PM - 3:10 PM Contrast Between Open And Endovascular Repair Of Thoracoabdominal Aneurysms
 
3:10 PM - 3:25 PM Elephant Trunk Technique For The Treatment Of Extensive Thoracic Aortic Aneurysms
 
3:25 PM - 3:40 PM Spinal Cord Protection For TAA Repair
 
3:40 PM - 3:55 PM Endovascular Approaches To Aortic Arch Disease
 
3:55 PM - 4:15 PM Break
END OF SESSION 3
 
SESSION 4 SCHEDULE
Wednesday
SESSION 4: NEW HORIZONS IN CARDIOVASCULAR SURGERY: MANAGEMENT OF AORTIC DISEASE - PART 2
Moderators: / TBD
x
4:15 PM - 6:00 PM Follow-up Case Studies: Management And Outcome
  Presenters(s):Hazim J. Safi, MD  
6:00 PM - 6:00 PM Adjourn. New Horizons in Cardiovascular Surgery continues on Thursday morning in the Grand Ballroom, 3rd floor.
END OF SESSION 4
 
SESSION 5 SCHEDULE
Wednesday
SESSION 5: ENDOVENOUS MANAGEMENT OF VARICOSE VEINS - PART 1
Moderators: / TBD
x
8:00 AM - 8:09 AM Welcoming Remarks
 
8:10 AM - 8:19 AM How To Identify The Best Patients For Endovenous Thermal Ablation
 
8:20 AM - 8:29 AM Which Patients Are Not Suitable For Endovenous Thermal Ablation?
 
8:30 AM - 8:39 AM Generating The Venous Map With Duplex Ultrasound
 
8:40 AM - 8:49 AM Great Saphenous vs. Small Saphenous Vein Ablation: Similarities And Differences Of Procedure
 
8:50 AM - 8:59 AM Endovenous Thermal Ablation: How I Choose Between RF Or Laser
 
9:00 AM - 9:09 AM Catheter-Directed Foam Sclerotherapy Treatment Of Saphenous Vein Incompetence
 
9:10 AM - 9:19 AM Lessons Learned After 3,000 Endovenous Ablations
 
9:20 AM - 9:35 AM Panel Discussion
9:36 AM - 9:45 AM Fire, Foam, And Knife For Varicose Veins: What Have Prospective Randomized Clinical Trials Taught Us?
 
9:46 AM - 9:55 AM What Studies Are Needed To Help Vein Doctors Treat Patients Better?
 
9:56 AM - 10:05 AM Preservation Of The Saphenous Vein In Patients With Varicose Veins
 
10:06 AM - 10:15 AM The CHIVA Approach To Varicose Vein Treatment
 
10:16 AM - 10:25 AM Matrix Metalloproteinases And Varicose Veins
 
10:26 AM - 10:35 AM Current Information On The Development And Treatment Of Venous Ulcers
 
10:36 AM - 10:45 AM How To Treat Ascending GSV Superficial Thrombophlebitis
 
10:46 AM - 10:54 AM Ileofemoral Venous Reflux And Obstruction: Diagnosis And Treatment
 
10:55 AM - 11:04 AM Venous Stenting: When, Where, Whom, How?
 
11:05 AM - 11:14 AM Deep Vein Considerations During Superficial Venous Treatment
 
11:15 AM - 11:24 AM The Future Of Venous Imaging: Will It Be Duplex Ultrasound, MRV, Or CTV?
 
11:25 AM - 11:34 AM Pelvic Venous Syndromes
 
11:35 AM - 11:44 AM Are Surgeons Letting Vein Care Slip Away?: Are Phlebologists Taking Over?
 
11:45 AM - 12:00 PM Panel Discussion
12:00 PM - 12:30 PM Lunch Break
END OF SESSION 5
 
SESSION 6 SCHEDULE
Wednesday
SESSION 6: ENDOVENOUS MANAGEMENT OF VARICOSE VEINS - PART 2
Moderators: / TBD
x
12:30 PM - 12:39 PM DVT Update: Current Recommendations For Treatment And Prophylaxis
 
12:40 PM - 12:49 PM Current Data On Radiofrequency Ablation With The ClosureFAST Catheter
 
12:50 PM - 12:59 PM Venous Laser Updates: New Wavelength Or Fibers?
 
1:00 PM - 1:09 PM Management Of The Anticoagulated Patient Who Needs Endovenous Ablation And Phlebectomy
 
1:10 PM - 1:19 PM Phlebectomy, Trivex, Or Sclerotherapy For Bulging Varicose Vein Tributaries?
 
1:20 PM - 1:29 PM Foam vs. Liquid Sclerotherapy In The Management Of Varicose Veins
 
1:30 PM - 1:39 PM Considerations For Treatment Of Infrapopliteal Deep Venous Thrombosis
 
1:40 PM - 1:49 PM Thrombotic Complications Of Endovenous Therapy For Varicose Veins
 
1:50 PM - 1:59 PM Thrombophilia: When To Order? What To Order? How To Treat And For How Long?
 
2:00 PM - 2:09 PM Should Adjuvant Procedures Be Performed At The Same Time As Endothermal Ablation?: Evidence Based
 
2:10 PM - 2:19 PM When Should Perforators Be Considered For Treatment?
 
2:20 PM - 2:29 PM Recurrent Varicose Veins: Can They Be Prevented? Can They Be Treated Effectively?
 
2:30 PM - 2:39 PM Role Of Laser vs. Sclerotherapy For Spider Telangiectasias?
 
2:40 PM - 2:49 PM Management Of Venous Malformations: Cut, Cook, Squirt?
 
2:50 PM - 3:00 PM Complications Of Foam Sclerotherapy: What I Have Witnessed
 
3:00 PM - 3:10 PM Establishing VTE Protocols For Prevention And Intervention
 
3:10 PM - 3:20 PM Building Your DVT Practice
 
3:20 PM - 3:50 PM Ask The Panel
  Panelist(s): Jose I. Almeida, MD, FACS, RVT / Lowell S. Kabnick, MD, FACS, FACPh / Ronald G. Bush, MD / Edward G. Mackay, MD / Thomas F. O'Donnell, Jr., MD / Peter F. Lawrence, MD / Peter J. Pappas, MD / Peter H. Lin, MD  
3:50 PM - 3:50 PM Adjourn
END OF SESSION 6
 
SESSION 7 SCHEDULE
Wednesday
SESSION 7: WOUNDS - PART 1
Moderators:TBD
x
8:00 AM - 8:10 AM Opening Remarks
 
PART 1A: NEW CONCEPTS IN WOUND CARE
Moderator(s): TBD  
8:10 AM - 8:20 AM Effect Of Different Frequencies Of Tensile Strain On Human Dermal Fibroblast Proliferation And Survival: Implication For The Practical Use
 
8:20 AM - 8:30 AM Discussion
8:30 AM - 8:40 AM The Use Of Skin Perfusion Pressure (SPP) With Pulse Volume Recording (PVR) To Accurately Assess Micro And Macro Circulation- Predicting Wound Healing
 
8:40 AM - 8:50 AM Discussion
8:50 AM - 9:00 AM Calciphylaxis And Martotell's Ulcer Need Fast Track Surgical Treatment
 
9:00 AM - 9:10 AM Discussion
9:10 AM - 9:20 AM Charged Polystyrene Microspheres: A New Technology For Treating Hard To Heal Chronic Wounds
 
9:20 AM - 9:30 AM Discussion
9:30 AM - 9:40 AM Autologous Platelet-Rich Fibrin Membrane In The Treatment Of Patients With Chronic Lower Extremity Ulcers
 
9:40 AM - 9:50 AM Discussion
9:50 AM - 10:00 AM Panel Discussion
10:00 AM - 10:30 AM Break / Visit Exhibits
PART 1B: MEETINGS SUMMARY
Moderator(s): TBD  
10:30 AM - 11:00 AM Best From WUWHS Meeting 2008
 
11:00 AM - 11:15 AM Discussion
11:15 AM - 11:45 AM Best From DFCON Meeting
 
11:45 AM - 12:00 PM Discussion
12:00 PM - 1:00 PM Lunch Break
END OF SESSION 7
 
SESSION 8 SCHEDULE
Wednesday
SESSION 8: WOUNDS - PART 2
Moderators:TBD
x
PART 2A: WOUND HEALING SOCIETIES
Moderator(s): TBD  
1:00 PM - 1:10 PM Introducing The Swiss Association for Wound Care (SAfW)
 
PART 2B: EVIDENCE BASED MEDICINE IN WOUND CARE
Moderator(s): TBD  
1:10 PM - 1:20 PM An Overview Of Level 1 Evidence From Cochrane Systematic Reviews On Systemic Wound Care
 
1:20 PM - 1:30 PM Discussion
1:30 PM - 1:40 PM Effectiveness Of Iodine In Wound Care: A Systematic Review
 
1:40 PM - 1:50 PM Discussion
1:50 PM - 2:00 PM Applying Evidence-Based Wound Healing To Difficult Chronic Wounds
 
2:00 PM - 2:10 PM Discussion
2:10 PM - 2:20 PM Evidence Informed Practice: A New Approach To Evidence Based Medicine
 
2:20 PM - 2:30 PM Discussion
2:30 PM - 3:00 PM Break / Visit Exhibits
PART 2C: CHALLENGES OF INTERDISCIPLINARY WOUND TEAMS
Moderator(s): TBD  
3:00 PM - 3:10 PM How To Get The Interdisciplinary Team To Talk And To Work In The Clinic
 
3:10 PM - 3:20 PM The Challenges Of An Open Access Interdisciplinary Foot Clinic And How To Overcome Them
 
3:20 PM - 3:30 PM The Role Of The Dermatologist In The Interdisciplinary Wound Team
 
3:30 PM - 3:40 PM The Role Of The Orthopedic Surgeon In The Interdisciplinary Wound Team
 
3:40 PM - 3:50 PM The Role Of The Vascular Surgeon In The Interdisciplinary Wound Team
 
3:50 PM - 4:00 PM The Role Of The Diabetologist In The Interdisciplinary Wound Team
 
4:00 PM - 4:20 PM Panel Discussion
PART 2D: VASCULAR INTERVENTIONS IN WOUND CARE
Moderator(s): TBD  
4:20 PM - 4:30 PM Debate: Balloon Angioplasty Is First Choice In All Wound Patients Suffering From Critical Limb Ischemia
 
4:30 PM - 4:40 PM Debate: Balloon Angioplasty Is Not First Choice In All Wound Patients Suffering From Critical Limb Ischemia
 
4:40 PM - 4:50 PM Discussion
4:50 PM - 5:00 PM Debate: Endovenous Ablation Is The Best Choice For Prevention Of Recurrent Venous Stasis Ulcers
 
5:00 PM - 5:10 PM Debate: Endovenous Ablation Is Not The Best Choice For Prevention Of Recurrent Venous Stasis Ulcers
 
5:10 PM - 5:20 PM Discussion
5:20 PM - 5:30 PM Closing Remarks
 
END OF SESSION 8
 
SESSION 9 SCHEDULE
Thursday
SESSION 9: TOPICS OF INTEREST TO INTERVENTIONALISTS, CARDIAC SURGEONS AND VASCULAR SURGEONS: ENDOVASCULAR HEART VALVES, ASCENDING AORTA AND ARCH LESIONS, IN SITU FENESTRATION, IMPROVED OPEN SURGICAL APPROACHES
Moderators: / TBD
x
6:35 AM - 6:40 AM Opening Remarks
 
6:40 AM - 6:45 AM Training Issues In Cardiac Surgery
  Presenters(s):Grayson H. Wheatley, MD  
6:46 AM - 6:51 AM Access Problems With Endovascular Aortic Valve Repair And How To Handle Them
 
6:52 AM - 6:57 AM Updated Experience With The Percutaneous Self-Expanding CORE Aortic Valve
 
6:58 AM - 7:03 AM Current State-of-the-Art With Endovascular Aortic Valve Repair
  Presenters(s):Martin B. Leon, MD  
7:04 AM - 7:09 AM Overview Of Percutaneous And Other Less Invasive Mitral Valve Treatments
  Presenters(s):Ted Feldman, MD  
7:10 AM - 7:15 AM The Future For Endovascular Repair Of Type A Aortic Dissections: Concept And Initial Clinical Experience
 
7:16 AM - 7:22 AM Panel Discussion
7:22 AM - 7:27 AM Where Are We With Branched Grafts For Treatment Of Aortic Arch Lesions?
 
7:28 AM - 7:33 AM Aortic External Graft Wrapping Makes Hybrid Procedures Successful And The Best Treatment For Aortic Arch Pathology: Technical Tips For Doing It Right
 
7:34 AM - 7:39 AM Open Repair Is Still The Best Option For Arch Aneurysms In Most Patients
  Presenters(s):Hazim J. Safi, MD  
7:40 AM - 7:45 AM Aortic Arch And TAA Repair Via A Left Thoracotomy: A New Technique
 
7:46 AM - 7:51 AM Is In Situ Fenestration The Way To Go For Revascularization Of Supra-Aortic Branches In Association With Endovascular Repair Of Arch Aneurysms?
 
7:52 AM - 7:57 AM Endovascular Total Arch Replacement Using In Situ Fenestration Methods: Techniques, Tricks And Early Clinical Experience
  Presenters(s):Bjõrn Sonesson, MD, PhD  
7:58 AM - 8:04 AM Panel Discussion
END OF SESSION 9
 
SESSION 10 SCHEDULE
Thursday
SESSION 10: MORE ABOUT THORACIC ENDOGRAFTING AND TREATMENT OF DISSECTING ANEURYSMS (5-MINUTE TALKS)
Moderators: / TBD
x
8:04 AM - 8:09 AM What Is Optimal Medical Treatment For Type B Aortic Dissections: How Well Does It Work?
  Presenters(s):Christoph A. Nienaber, MD, PhD  
8:10 AM - 8:15 AM Debate 1: All Acute Type B Aortic Dissections Should Be Treated With An Endograft: We Don’t Need Level I Evidence
 
8:16 AM - 8:21 AM Debate 1: Nonsense, We Do Need Level I Evidence Comparing Medical Treatment With TEVAR For Uncomplicated Type B Aortic Dissection: Early Results Of Such A Trial (The ADSORB Trial)
 
8:22 AM - 8:27 AM Lessons Learned In Endograft Treatment Of More Than 550 Patients With Type B Aortic Dissections: How To Manage Retrograde Type A Dissections
  Presenters(s):Wei Guo Fu, MD  
8:28 AM - 8:33 AM Debate 2: For Type B Aortic Dissections Short TEVAR Coverage Of The Primary Tear Is Best
 
8:34 AM - 8:39 AM Debate 2: For Type B Aortic Dissections TEVAR Should Cover The Entire Thoracic Aorta
 
8:40 AM - 8:45 AM Oral Anticoagulation In Type B Aortic Dissections Has A Beneficial Effect On Secondary Dilatation And Malperfusion
 
8:46 AM - 8:51 AM Potential Devices For Complete Endovascular Repair Of Complex Type B Aortic Dissecting Aneurysms: The Hollow Hat Small Endograft For Leaks At Branch Reentry Sites
  Presenters(s):Zaiping Jing, MD  
8:52 AM - 8:57 AM Experience With Endo TAA Repair With Branched Endografts: When Can This Technology Not Be Used?
 
8:58 AM - 9:03 AM Single Center Experience With Treatment Of Malperfusion From Type B Aortic Dissections
 
9:04 AM - 9:10 AM Panel Discussion
END OF SESSION 10
 
SESSION 11 SCHEDULE
Thursday
SESSION 11: NEW DEVELOPMENTS AND TECHNIQUES IN TEVAR AND DEALING WITH ITS COMPLICATIONS (5-MINUTE TALKS)
Moderators: / TBD
x
9:10 AM - 9:15 AM Debate 3: Left Subclavian Artery Coverage During TEVAR Is Relatively Safe: When Is It Not?
 
9:16 AM - 9:21 AM Debate 3: Left Subclavian Artery Flow Must Be Preserved During TEVAR: If Covered The Left Subclavian Must Be Revascularized
 
9:22 AM - 9:27 AM Management Of Recurrent Aneurysms After TEVAR From Endograft Failure Or Disease Progression
  Presenters(s):Geoffrey H. White, MD  
9:28 AM - 9:33 AM What Are Malignant Aortic Dissections And How Are They Best Treated Endovascularly: The MAD REDEEM Concept
  Presenters(s):Christoph A. Nienaber, MD, PhD  
9:34 AM - 9:39 AM Direct Placement Of Large Sheaths In The Aorta Or Common Iliacs For TEVAR: Techniques And Tricks For Doing It Safely
 
9:40 AM - 9:45 AM Computational Hemodynamics And Its Importance In Acute Thoracic Aortic Disease
 
9:46 AM - 9:51 AM New Endovascular Procedures For Better Treatment Of Chronic Type B Dissections With Aneurysm Formation
 
9:52 AM - 9:57 AM TEVAR After Previous AAA Repair Is Relatively Safe: When Is Spinal Drainage Necessary?
 
9:58 AM - 10:03 AM A Blood Test For Thoracic Aortic Aneurysms
 
10:04 AM - 10:09 AM Use Of Atrium ICAST Covered Stents To Treat Aortic Coarctation And Associated Aneurysms: Are They Safer Than Bare Stents?
 
10:10 AM - 10:18 AM Panel Discussion
END OF SESSION 11
 
SESSION 12 SCHEDULE
Thursday
SESSION 12: HOT TOPICS IN LOWER EXTREMITY ENDOVASCULAR TREATMENT (5-MINUTE TALKS)
Moderators: / TBD
x
6:40 AM - 6:45 AM Opening Remarks
 
6:45 AM - 6:50 AM Overview Of Atherectomy Devices: What Is The Evidence They Add Anything But Cost?
 
6:51 AM - 6:56 AM Debate 4: Rotational Atherectomy Devices Really Work In Certain Specific Situations: What Are They? What Is The Proof?
 
6:57 AM - 7:03 AM Debate 4: Atherectomy Devices Are A Waste Of Time And Money
 
7:04 AM - 7:09 AM Value And Limitations Of The ANGIOSCULPT Scoring/Cutting PTA Balloon For Infrapopliteal Lesions: 2-Year Results Of The MASCOT Trial: Will This Decrease The Need For Stents?
 
7:10 AM - 7:15 AM Cool Excimer Laser Assisted PTA vs. Balloon PTA With New Improved Balloons For Tibial Occlusive Disease Causing Critical Limb Ischemia (CLI): Is The Laser Of Real Value And When?
 
7:16 AM - 7:21 AM Tips, Tricks And Bailout Strategies For Subintimal Angioplasty Of Long Infrainguinal Occlusions
 
7:22 AM - 7:27 AM Debate 5: Update And 12-Month Results With Drug Eluting Balloons Show Clear Benefit For Treating SFA And Popliteal Lesions
 
7:28 AM - 7:33 AM Debate 5: It Is Not So Clear That Drug Eluting Balloons Work
 
7:34 AM - 7:39 AM Prevention And Treatment Of In-Stent Restenosis
 
7:40 AM - 7:45 AM Will Long Nitinol Stents (Like the 20 cm EVERFLEX) Replace Bypass Surgery For Long Fempop Occlusions?
 
7:46 AM - 7:58 AM Panel Discussion
END OF SESSION 12
 
SESSION 13 SCHEDULE
Thursday
SESSION 13: MORE LOWER EXTREMITY HOT TOPICS, ESPECIALLY REGARDING STENTS (5-MINUTE TALKS)
Moderators: / TBD
x
7:59 AM - 8:04 AM Role Of Current Stents In Lower Extremity Occlusive Disease In 2009: What Is The Most Recent Evidence Including That From The STRIDES And VIASTAR Studies?
 
8:05 AM - 8:10 AM 2-Year Results Of The ZILVER-PTX Drug-Eluting Stent For SFA Lesions
 
8:11 AM - 8:16 AM Status Of The TURBO BOOSTER Spectranetics Laser For Lower Extremity Occlusive Disease: Has It Changed Things?
 
8:17 AM - 8:22 AM New Concepts In Stent Design: The Micromesh-Covered SESAME Stent: Design And Clinical Experience
 
8:23 AM - 8:28 AM Technical Tips And Results Of Transpedal Approach For Revascularizing Tibial Artery Occlusions Which Cannot Be Crossed From Above
 
8:29 AM - 8:34 AM Indication And Techniques For Transpedal Approach In The Treatment Of Critical Limb Ischemia
 
8:35 AM - 8:40 AM New Technique For Distal PTA Of Tibial Arteries: The Pedal Arch Route For Access: Can It Work In Diabetics?
 
8:41 AM - 8:46 AM Need For Distal Embolic Filtration Devices With Lower Extremity Atherectomy And Laser Angioplasty
 
8:47 AM - 8:52 AM Incidence Of Embolization After Lower Extremity Percutaneous Revascularization
 
8:53 AM - 8:58 AM Choice Of Access For Below-Knee Interventions: Up And Over vs. Antegrade
 
8:59 AM - 9:10 AM Panel Discussion
END OF SESSION 13
 
SESSION 14 SCHEDULE
Thursday
SESSION 14: MORE LOWER EXTREMITY HOT TOPICS (5-MINUTE TALKS)
Moderators: / TBD
x
9:10 AM - 9:15 AM Devices And Simplified Strategies For Crossing Total Occlusions
 
9:16 AM - 9:21 AM Value And Limitations Of Drug-Eluting Stents (DES) In The Treatment Of Critical Limb Ischemia (CLI)
 
9:22 AM - 9:27 AM DES vs. Bare Metal Stents (BMS) To Treat Below-Knee Lesions: 1-Year Angiographic Results Of The DESTINY Trial
 
9:28 AM - 9:33 AM Below-Knee DES For CLI: Results With 2-Year Follow-Up
 
9:34 AM - 9:39 AM Intraoperative Stem Cell Treatment Delivered With A Novel Device To Improve Limb Salvage Rates
  Presenters(s):Ralf R. Kolvenbach, MD  
9:40 AM - 9:45 AM Debate 6: DES In The SFA Will Have A Positive Impact
 
9:46 AM - 9:51 AM Debate 6: DES In The SFA Are Not Needed
 
9:52 AM - 9:57 AM 5-Year Results With Zilver Stents Across The Knee Are Good
 
9:58 AM - 10:03 AM With Foot Gangrene And Ulceration Wound Healing Occurs Faster And Better With A Bypass Than With Endovascular Treatments
 
10:04 AM - 10:18 AM Panel Discussion

CONCLUSION OF PROGRAMS A AND B. AIMsymposium continues in the Trianon Ballroom, 3rd Floor as Plenary Sessions. VEITHsymposium continues in the Grand Ballroom, 3rd Floor as Plenary Sessions.
END OF SESSION 14
 
SESSION 15 SCHEDULE
Thursday
SESSION 15: NEW DEVELOPMENTS IN SFA AND CRURAL ARTERY TREATMENTS AND MANAGEMENT OF CLI (5-MINUTE TALKS)
Moderators: / TBD
x
10:20 AM - 10:25 AM Advanced Interventional Techniques In Fempop And Crural Arteries For CLI: The Role Of Plain Old Balloon PTA (POBA)
 
10:26 AM - 10:31 AM Debate 7: New Developments In Subintimal Angioplasty: It Is A Desirable Method
 
10:32 AM - 10:37 AM Debate 7: Subintimal Angioplasty For CLI Is A Technical Error Not A First Choice Procedure
 
10:38 AM - 10:43 AM Advantages, Disadvantages And Technical Tips For Subintimal Angioplasty
 
10:44 AM - 10:49 AM New Options For Restenosis In The SFA
 
10:50 AM - 10:55 AM ICAST Balloon-Expandable Stents And Covered Stents In The Lower Extremity: Results Of The ICARUS Trial
 
10:56 AM - 11:01 AM Endovascular Methods To Treat Severely Calcified SFAs Successfully
 
11:02 AM - 11:07 AM Panel Discussion
Moderator(s): TBD / TBD  
11:07 AM - 11:12 AM Debate 8: TASC II Is A Good Decision Making Tool
 
11:13 AM - 11:18 AM Debate 8: TASC II Is Too Complicated And Not Worthwhile As A Treatment Guide
 
11:19 AM - 11:24 AM Methods For Stenting Infrainguinal Lesions At Bifurcations Safely And Effectively: Something We All Need To Know
 
11:25 AM - 11:30 AM Stenting Of Lesions At Tibial Bifurcations: Indications And Techniques
 
11:31 AM - 11:36 AM Debate 9: Endovascular Techniques Can Effectively Treat Virtually All Patients With CLI: Open Surgery Is Almost Never Needed
 
11:37 AM - 11:42 AM Debate 9: What Proportion Of CLI Patients Will Need An Open Surgical Procedure At Some Point In Their Course: An Interventionalist’s Perspective
 
11:43 AM - 11:48 AM Debate 9: What Proportion Of CLI Patients Will Need An Open Surgical Procedure At Some Point In Their Course: A Vascular Surgeon’s Perspective
 
11:49 AM - 11:54 AM Debate 9: Open Surgical Bypass Is The Procedure Of Choice For CLI Revascularization
 
11:55 AM - 12:00 PM Panel Discussion
12:00 PM - 1:00 PM Lunch Served in the Exhibit Hall and in Other Designated Areas
END OF SESSION 15
 
SESSION 16 SCHEDULE
Thursday
SESSION 16: NEW DEVELOPMENTS IN TEVAR AND EVAR (5-MINUTE TALKS)
Moderators: / TBD
x
1:00 PM - 1:05 PM A New Technique For In Situ Fenestration To Revascularize Aortic Branches Using Electro-Magnetic Navigation
 
1:06 PM - 1:11 PM When Can Type I Endoleaks After EVAR Be Safely Observed?
 
1:12 PM - 1:17 PM How Well Is The Petticoat Concept (Open Stent Distal to a Stent-Graft) Working For Treatment Of Type B Dissections?
  Presenters(s):Christoph A. Nienaber, MD, PhD  
1:18 PM - 1:23 AM Update On The STABLE Trial With A Thoracic Endograft, Comprised Of A Covered Stent Above And An Open Stent Below, For Type B Aortic Dissections
 
1:24 PM - 1:29 PM Experience With Hybrid Grafting Of The Visceral And Renal Arteries From The Ascending Aorta: Is It A Better Way?
 
1:30 PM - 1:35 PM 8-Year Experience With The VORTEC Procedure: Viabahn Technique For Revascularization Of Aortic Branch Vessels Without Clamping Or Circumferential Dissection: Is It A Better Way?
 
1:36 PM - 1:41 PM An Improved Preloaded Fenestrated Endograft For Pararenal AAAs: Advantages, Technical Description And Initial Clinical Experience
 
1:42 PM - 1:47 PM Panel Discussion
Moderator(s): TBD / TBD  
1:47 PM - 1:52 PM Tissue Glue And Coil Embolization For Difficult Type I Endoleaks: Technique And Midterm Results
 
1:53 PM - 1:58 PM Optimal Techniques For Surveillance After EVAR In 2009 And Beyond
 
1:59 PM - 2:04 PM AAA Sac Pressure Measurements Are Helpful Since Many Type II Endoleaks Should Be Treated Because They Can Cause AAA Ruptures
 
2:05 PM - 2:10 PM Technique For Continuous Supraceliac Balloon Aortic Control With Ruptured AAAs And Hemodynamic Collapse (Video Presentation)
 
2:11 PM - 2:16 PM A New System For Electronic Image Marking To Simplify Interventional Procedures
 
2:17 PM - 2:22 PM Is EVAR The Treatment Of Choice For Inflammatory AAAs?
 
2:23 PM - 2:28 PM Panel Discussion
END OF SESSION 16
 
SESSION 17 SCHEDULE
Thursday
SESSION 17: CRITICAL EVALUATION OF CAROTID ARTERY STENTING (CAS) IN NOVEMBER 2009 (5-MINUTE TALKS)
Moderators: / TBD
x
2:28 PM - 2:33 PM Debate 10: CAS Is Dead Based On Population Based Studies And Level I Evidence
 
2:34 PM - 2:39 PM Debate 10: CAS Is Not Dead: It Will Have A Role In Symptomatic Patients When Used With New And Better Technology (Better Stents/Flow Reversal) And Better Patient Selection
 
2:40 PM - 2:45 PM Anatomic And Lesion Characteristics Are Accurate Predictors Of Stroke From CAS: What Technique Is Best For Determining This?
 
2:46 PM - 2:51 PM New Key Information From The SPACE Trial: Cerebral Protection vs. No Cerebral Protection: Timing Of Strokes With CAS; Incidence Of Restenosis After CAS And CEA; Open vs. Closed Stents – Which Is Best?
 
2:52 PM - 2:58 PM Results Of The ICSS Trial: Randomized Comparison Of CAS vs. CEA In Symptomatic Patients
 
2:59 PM - 3:04 PM 1-Year Results Of The CREST Trial: Randomized Comparison Of CAS vs. CEA In Symptomatic And Asymptomatic Patients
 
3:05 PM - 3:10 PM Where Do We Go From Here With Randomized Trials Of CAS vs. CEA: Do We Need More Trials In Asymptomatic Patients With A Best Medical Treatment Arm; More Trials With Better Patient Selection; Or More Trials With Better Technology For CAS (Flow Reversal and Better Stent Systems)?
 
3:11 PM - 3:16 PM CAS With Proximal Protection (Flow Cessation/Reversal) And Hybrid (Cristallo) Stents: Will This Be A Better And Universally Safe Approach?
 
3:17 PM - 3:22 PM Debate 11: Indirect Markers Of Cerebral Embolization (TCD and Diffusion-Weighted MRI) Are Of Great Value In Differentiating Strategies For Embolic Protection In CAS
 
3:23 PM - 3:28 PM Debate 11: Indirect Markers Of Cerebral Embolization (TCD and DW-MRI) Are Of Little Value In Differentiating Strategies For Embolic Protection In CAS Because Most Strokes With CAS Occur Before Or After Embolic Protection Devices Are Functioning
 
3:29 PM - 3:34 PM Imaging Suite Of The Future Will Combine Many Modalities: What Can Be Combined With Fluoroscopy To Facilitate Endovascular Procedures?
 
3:35 PM - 3:40 PM Panel Discussion
Moderator(s): TBD / TBD / TBD  
3:40 PM - 3:45 PM Debate 12: Medical Treatment Is Best For Most Asymptomatic Patients With Carotid Stenosis
 
3:46 PM - 3:51 PM Debate 12: CEA Or CAS, Not Medical Treatment, Is Best For Most Asymptomatic Patients With >60% Carotid Stenosis
 
3:52 PM - 3:57 PM Interventional Treatment (CAS or CEA) Should Await New Diagnostic Methods: What Is On The Horizon?
 
3:58 PM - 4:03 PM Best Medical Treatment Is Currently The Optimal Management For >60% Carotid Stenosis In Asymptomatic Patients: What Is Needed To Maximize The Benefit Of CAS In Such Patients?
 
4:04 PM - 4:09 PM Value Of Intense Lipid Lowering Treatment In Patients With Asymptomatic Carotid Stenosis
 
4:10 PM - 4:15 PM How To Identify Vulnerable Carotid Plaques In Asymptomatic Patients Noninvasively With Molecular Imaging
 
4:16 PM - 4:21 PM How To Predict Which Asymptomatic Patients Are At High Risk For Stroke So They Can Be Treated Invasively Without Treating All Asymptomatic Patients: Present Status And Future Possibilities
 
4:22 PM - 4:27 PM Effect Of Exercise And Statins On Carotid Plaques: Implications For Invasive Treatment Of Asymptomatic Patients
 
4:28 PM - 4:33 PM Status Of The TACIT Trial: Will We Ever Know The Truth About How Asymptomatic Patients With Carotid Stenosis Should Be Treated?: Will The Stimulus Package Save The Day For TACIT?
 
4:34 PM - 4:39 PM Panel Discussion
END OF SESSION 17
 
SESSION 18 SCHEDULE
Thursday
SESSION 18: UPDATE ON STENT GRAFTS IN THE SFA AND POPLITEAL ARTERIES (5-MINUTE TALKS)
Moderators: / TBD
x
4:39 PM - 4:44 PM 12-Year Experience With VIABAHN Stent-Grafts For Treatment Of Long SFA Occlusions: Technical Tips And 5 And 10-Year Patency Data
 
4:45 PM - 4:50 PM Single Center And Multicenter Results (VIBRANT Trial) Of VIABAHN Stent-Grafts vs. Uncovered Nitinol Stents For SFA Occlusive Disease
 
4:51 PM - 4:56 PM Edge Stenosis After SFA Stent-Grafting For Occlusive Disease: What Do We Know And What Can Be Done To Prevent Or Treat It: Will Heparin Bonding Improve Results?
 
4:57 PM - 5:02 PM Coverage Of Collaterals With SFA Stent-Grafts: Is It Or Is It Not A Problem?
 
5:03 PM - 5:08 PM Are Reentry Devices Worth The Effort In Complex SFA Occlusions?
 
5:09 PM - 5:14 PM 2-3-Year Results With Tissue Covered Stents For SFA Occlusive Disease: Technical Improvements In The System
 
5:15 PM - 5:20 PM Long-Term Follow-up Of VIABAHN Stent-Grafts To Treat Popliteal Aneurysms: Tips, Tricks, Precautions And When Not To Use
 
5:21 PM - 5:26 PM Panel Discussion
END OF SESSION 18
 
SESSION 19 SCHEDULE
Thursday
SESSION 19: UPDATES AND NEW CONCEPTS IN VASCULAR DISEASE (5-MINUTE TALKS)
Moderators: / TBD
x
5:26 PM - 5:31 PM 2-3-Year Results With Drug Eluting Stents (DES): Does Catch-Up Stenosis And Mortality Occur And Why?
 
5:32 PM - 5:37 PM Midterm Efficacy And Long-Term Outlook With Coronary Drug Eluting Stents And Absorbable Drug Eluting Stents (The ABSORB Trial): Is There A Downside Beside Costs?
  Presenters(s):Martin B. Leon, MD  
5:38 PM - 5:43 PM Vulnerable Plaques: Implications For Vascular Surgeons And Interventionalists And What Can Be Done About Them?
 
5:44 PM - 5:49 PM Findings And Interpretations Of The SYNTAX Trial: Is It A Winner For Stenting Or CABG In Severe Coronary Artery Disease With Triple Vessel Or Left Main Disease?
 
5:50 PM - 5:55 PM Will Biodegradable Stents Replace Drug Eluting Stents?
 
5:56 PM - 6:01 PM Surgical And Endovascular Treatment Of Takayasu’s Arteritis: Which Treatment Should Be Used And When?
 
6:02 PM - 6:07 PM Radiation Exposure To The Interventionalist: Innovations And Precautions To Lessen It
 
6:08 PM - 6:13 PM Panel Discussion
END OF SESSION 19
 
SESSION 20 SCHEDULE
Thursday
SESSION 20: PREVENTION AND TREATMENT OF COMPLICATIONS (5-MINUTE TALKS)
Moderators: / TBD
x
6:13 PM - 6:18 PM Superficial Femoral Artery Access For Endovascular Procedures When The Common Femoral Cannot Be Used Due To Scarring, Disease Or Infection
 
6:19 PM - 6:24 PM Neurological Complications Of TEVAR: How To Prevent And Treat Them
 
6:25 PM - 6:30 PM Advantages Of And Indications For Use Of Bivalirudin Rather Than Heparin For Endovascular Procedures
 
6:31 PM - 6:36 PM Technical Tips On Managing Abdominal Compartment Syndrome And Open Abdomen Treatment After EVAR For Ruptured AAA
 
6:37 PM - 6:42 PM Techniques For Simplified Endovascular Management Of Iatragenic Subclavian Artery Injury
 
6:43 PM - 6:48 PM EMPIRE Trial Of The Gore Parodi Flow Reversal Embolic Protection Device In CAS: Its Particular Value In Symptomatic Patients And Octogenarians
 
6:49 PM - 6:54 PM Technique For Placement Of Large Palmaz Stent For Proximal Neck Problem During EVAR: What Balloon, Sheath And Precautions Are Needed?
 
6:55 PM - 7:00 PM Use Of Covered Palmaz Stent As A Neck Extender In EVAR
  Presenters(s):Ralf R. Kolvenbach, MD  
7:01 PM - 7:06 PM What The Vascular Surgeon Or Interventionalist Needs To Know About Discontinuing Plavix In A Patient With A Drug Eluting Coronary Stent Needing Another Procedure
 
7:07 PM - 7:15 PM Panel Discussion
END OF SESSION 20
 
SESSION 21 SCHEDULE
Friday
SESSION 21: MORE ABOUT NEW TECHNIQUES AND NEW TECHNOLOGY (5-MINUTE TALKS)
Moderators: / TBD
x
6:40 AM - 6:45 AM Technical Tips For Precise Placement Of A Large Palmaz Stent During EVAR
 
6:46 AM - 6:51 AM All Stents Are Not The Same: New And Improved Stents Can Improve Results: Are There Ways Other Than Drug Coatings To Improve Results?
 
6:52 AM - 6:57 AM ROX AV Fistula For Treatment Of COPD: Overview Of The European Experience
 
6:58 AM - 7:03 AM Muscle Sparing, Retroperitoneal Approach For Anterior Lumbar Spine Surgery With A PTFE Membrane (PRECLUDE Vessel Guard From Gore) To Protect The Aorta And IVC From Metal Fixation Hardware
 
7:04 AM - 7:09 AM Do Drug Eluting Stents In Crural Arteries Make A Difference In Below-the-Ankle Angioplasty And Stenting: The Last Frontier
 
7:10 AM - 7:15 AM Primary Intracranial Stenting For Acute Stroke: Early Results And When Not To Do It
 
7:16 AM - 7:21 AM Internal Sealing Of Ruptured AAAs With A Catheter Delivered Liquid-to-Solid Embolic Agent (ONYX): It Can Work
 
7:22 AM - 7:28 AM Panel Discussion
END OF SESSION 21
 
SESSION 22 SCHEDULE
Friday
SESSION 22: MORE ABOUT THORACIC, THORACOABDOMINAL AND PARARENAL ANEURYSMS: FENESTRATED BRANCHED AND CHIMNEY GRAFTS (5-MINUTE TALKS)
Moderators: / TBD
x
7:28 AM - 7:33 AM First Description And Subsequent Experience With The “Chimney Or Snorkel” Procedure For Revascularizing Aortic Branches Threatened By Endograft Coverage
 
7:34 AM - 7:39 AM Present Status And New Developments In Use Of Chimney Grafts: They May Take The Place Of Many Fenestrated And Branched Grafts For Juxta- Para- And Suprarenal Aneurysms
 
7:40 AM - 7:45 AM Debate 14: Use Of Extended Chimney Grafts Facilitate Repair Of Suprarenal And Pararenal Aneurysms And Make The Need For Fenestrated And Branched Grafts Questionable
  Presenters(s):Armando C. Lobato, MD, PhD  
7:46 AM - 7:51 AM Debate 14: Fenestrated And Branched Grafts Are Not Threatened by Chimney Grafts
 
7:52 AM - 7:57 AM Updated 5-Year Experience With Fenestrated And Branched Endografts For Pararenal And Thoracoabdominal Aneurysms: Do They Work After Previous Open AAA Repair Or EVAR?
 
7:58 AM - 8:03 AM Panel Discussion
Moderator(s): TBD / TBD  
8:03 AM - 8:08 AM TEVAR Is The Best Treatment For Ruptured Thoracic Aneurysms: Technical Tips
 
8:09 AM - 8:14 AM Standardized Off-the-Shelf Multibranched Graft Components For Endovascular Thoracoabdominal Aneurysms Repair
 
8:15 AM - 8:20 AM Durability Issues With Branched Aortic Arch Endografts Make Fenestrated And Chimney Grafts In This Area Questionable As A Long-Term Solution
 
8:21 AM - 8:26 AM Open Surgery Is Still The Gold Standard For Repair Of Thoracoabdominal Aneurysms In Good Risk Patients
  Presenters(s):Richard P. Cambria, MD  
8:27 AM - 8:32 AM Scallop Designed Endograft To Improve Distal Sealing And Fixation With TEVAR
 
8:33 AM - 8:38 AM New Endovascular Stapler To Prevent Graft Migration After TEVAR
  Presenters(s):Ralf R. Kolvenbach, MD  
8:39 AM - 8:44 AM How Does 3-D CT Help In Prevention Of Spinal Cord Ischemia With TEVAR?
 
8:45 AM - 8:52 AM Panel Discussion
END OF SESSION 22
 
SESSION 23 SCHEDULE
Friday
SESSION 23: NEW DEVELOPMENTS IN THE MANAGEMENT OF LOWER EXTREMITY ISCHEMIA (5-MINUTE TALKS)
Moderators: / TBD
x
8:52 AM - 8:57 AM Proportion Of Critical Ischemia Patients Who Require An Open Surgical Revascularization In A Center Favoring Endovascular Treatment
 
8:58 AM - 9:03 AM Adjuvant Benefit Of Angioplasty In Patients With Mild-to-Moderate Intermittent Claudication (MIMIC) Managed By Supervised Exercise, Smoking Cessation And Best Medical Treatment: Femoropopliteal Results
 
9:04 AM - 9:09 AM In The Endovascular Treatment Of Multilevel Occlusive Disease Causing Critical Limb Ischemia (CLI), Should The Distal Lesions Also Be Treated And Why?
 
9:10 AM - 9:15 AM Technical Tips And Tricks To Facilitate Difficult Lower Extremity Revascularization For CLI
 
9:16 AM - 9:21 AM The Evidence That Heparin-Bonded PTFE Grafts (PROPATEN) Are Better Than Uncoated PTFE And As Good As Vein Grafts: Where Do We Go From Here?
 
9:22 AM - 9:27 AM With PTA And Stents In The Aorta And Iliac Arteries, Is There Still A Place For Aortobifemoral Bypass?
 
9:28 AM - 9:33 AM New Developments In Open Surgery For Popliteal Aneurysms: Value Of Preop Thrombolysis, Posterior Approach And Postop Aneurysm Surveillance
 
9:34 AM - 9:39 AM Update On The Hanson Robotic System For Catheter Tip Manipulation And For Cannulating Aortic Branch Vessels
 
9:40 AM - 9:45 AM Tips And Tricks For The Successful Treatment Of Plantar And Diabetic Ulcers
 
9:46 AM - 9:52 AM Panel Discussion
Moderator(s): TBD / TBD  
9:53 AM - 9:58 AM Lysis (TPA) And Laser For Critical Limb Ischemia From Long Total Occlusions
 
9:59 AM - 10:04 AM Functional Status Of CLI Patients Predicts Outcome After Leg Bypass Surgery
 
10:05 AM - 10:10 AM How To Predict Patient Survival And Mortality In CLI Patients: Based On The BASIL Trial
 
10:11 AM - 10:16 AM Popliteal Entrapment Syndromes: What’s New With Classification, Pathogenesis And Treatment?
 
10:17 AM - 10:22 AM Optimal Antiplatelet And Anticoagulant Therapy With Lower Extremity Bypasses: Latest Best Treatment Based On Good Data
 
10:23 AM - 10:28 AM Status Of Bone Marrow And Stem Cell Transplants For CLI
 
10:29 AM - 10:34 AM Update On Angiogenic Gene Therapy For CLI: Where Is It Headed?
 
10:35 AM - 10:43 AM Panel Discussion
END OF SESSION 23
 
SESSION 24 SCHEDULE
Friday
SESSION 24: ADVANCES IN MEDICAL TREATMENT AND TREATMENT OF MEDICAL PROBLEMS: MEDICAL RISKS IN VASCULAR SURGERY AND WHAT CAN BE DONE TO REDUCE THEM (5-MINUTE TALKS)
Moderators: / TBD
x
10:43 AM - 10:48 AM Factors Predictive Of Mortality In Vascular Surgery Patients From A NSQIP Database: Does Functional Status And Obesity Matter?
 
10:49 AM - 10:58 AM Update On Value Of Statin Drugs In Vascular Patients And The Over 50 Population: Should All Our Patients Be On Them; Should All Of Us Be On Them? (9-Minute Talk)
 
10:59 AM - 11:04 AM Primary Prevention Of Atherosclerosis: Should Everyone >50 Be On Statins; Should They Be In The Drinking Water?
 
11:05 AM - 11:10 AM How Should Statins Be Used Optimally: Dosage, Drug, Modulation Of Therapy According To Lipid Levels?
 
11:11 AM - 11:16 AM Value Of Continuous ECG Monitoring With An Implantable System (REVEAL XT) In Vascular Surgery Patients: What New Problems Can Be Detected And What Is The Prognostic Significance?
 
11:17 AM - 11:22 AM Medical Therapy And Advances In Critical Limb Ischemia: How Vascular Medicine And Cardiology Can Fundamentally Improve Outcomes
 
11:23 AM - 11:28 AM How Should Beta Blockers Be Used In Vascular Surgery Patients In Light Of The POISE Trial Showing They Can Increase Stroke And Death Rates?
 
11:29 AM - 11:34 AM Update On The RHEOS Trial Of Carotid Sinus Stimulation For Poorly Controlled Hypertension: Is It A New Horizons For Vascular Surgeons?
 
11:35 AM - 11:50 AM Panel Discussion
11:50 AM - 12:48 PM Lunch Served in the Exhibit Hall and in Other Designated Areas
END OF SESSION 24
 
SESSION 25 SCHEDULE
Friday
SESSION 25: MORE ON AORTIC ANEURYSMS AND THEIR TREATMENT (5-MINUTE TALKS)
Moderators: / TBD
x
12:48 PM - 12:53 PM The New Cook PROFORM Thoracic Endograft To Provide Better Proximal Arch Conformability
  Presenters(s):Tilo Kölbel, MD, PhD  
12:54 PM - 12:59 PM A Multilayered Uncovered Stent For Treating Aneurysms With Preservation Of Branch Flow: Can It Really Work?
  Presenters(s):Edward B. Diethrich, MD  
1:00 PM - 1:05 PM Results Of French ACE Trial Comparing EVAR With Open Repair (OR) For Moderate Sized AAAs
 
1:06 PM - 1:11 PM 2-Year Results Of The U.S. VA Open vs. Endovascular AAA Repair (OVER) Trial
  Presenters(s):Frank A. Lederle, MD  
1:12 PM - 1:17 PM Are Long-Term Results Of EVAR Worse Than OR: Data From The Dutch DREAM Trial: What Other Findings Will Confirm Or Refute Them?
 
1:18 PM - 1:23 PM Update On The ENGAGE ENDURANT Global Registry: Why This Third Generation Device Is Better And Applicable To More Patients
 
1:24 PM - 1:29 PM Panel Discussion
1:30 PM - 1:35 PM Does EVAR And Its Follow-up Cause Renal Failure: What Should Be Done About It?
 
1:36 PM - 1:41 PM Proportion Of Ruptured AAAs Suitable For EVAR In View Of Chimney And Homemade Fenestrated Endografts
  Presenters(s):Timothy A. Resch, MD, PhD  
1:42 PM - 1:47 PM Debate 15: Should Type II Endoleaks Ever Be Treated: The Futility Of Intrasac Pressure Measurements
 
1:48 PM - 1:53 PM Debate 15: CardioMems Pressure Sensing Simplifies And Decreases The Cost Of Surveillance After EVAR And Helps To Determine When Type II Endoleaks Should Be Treated
 
1:53 PM - 2:00 PM Panel Discussion
END OF SESSION 25
 
SESSION 26 SCHEDULE
Friday
SESSION 26: PROGRESS IN VASCULAR IMAGING AND MISCELLANEOUS TOPICS (5-MINUTE TALKS)
Moderators: / TBD
x
2:00 PM - 2:05 PM Advantages And Limitations Of CTA And MRA In Lower Limb Ischemia: 2009 State-of-the-Art For Preprocedural Imaging For Treatment Planning
 
2:06 PM - 2:11 PM How Does 3-D Rotational Angiography Help In Endovascular Procedures?
 
2:12 PM - 2:17 PM Update On New Developments In Intravascular Ultrasound And Its Applications For Endovascular And Vascular Procedures: What Can Be Accomplished With The VOLCANO System?
 
2:18 PM - 2:23 PM How Does Blood Pool MRA Contrast Agents Improve Vascular Imaging: How Do They Work?
 
2:24 PM - 2:29 PM What Is Possible With Improved 3-D And Dynamic 3-D (4-D) MRA And CTA Imaging?
 
2:30 PM - 2:35 PM 4-D Dynamic CT And Its Impact On Endograft Sizing
 
2:36 PM - 2:41 PM Pitfalls And Precautions With Aortic Imaging With CTA
 
2:42 PM - 2:48 PM Panel Discussion
Moderator(s): TBD / TBD  
2:48 PM - 2:53 PM Why Brain MRI Studies Must Be Obtained Before Treatment Of Carotid Stenosis By CAS
 
2:54 PM - 2:59 PM The Importance Of Sub-Clinical Brain Damage After CAS vs. CEA: Correlations Between Serum Markers Of Neuronal Injury (NSE And S100 ß Proteins), Diffusion-Weighted MRI (DW-MRI) And Mini-Mental State Examination (MMSE)
 
3:00 PM - 3:05 PM Primary Vertebral Artery Aneurysms Are A Local Manifestation Of Connective Tissue Disease
 
3:06 PM - 3:11 PM Current Aspiration Catheter Techniques To Prevent Periprocedural And Post-Procedural Emboli During CAS
 
3:12 PM - 3:17 PM First Randomized Trial Showing Positive Results From Pharmacologically-Induced Angiogenesis (Gene Therapy) In Critical Limb Ischemia
 
3:18 PM - 3:23 PM Tips And Tricks To Make Pedal Bypass Successful And Valuable In The Endovascular Era: Does Deep Venous Arterialization Make A Difference?
 
3:24 PM - 3:29 PM Anatomical Suitability Of AAAs For EVAR In Ethnic Chinese: Which Graft Is Best For Most?
 
3:30 PM - 3:36 PM Panel Discussion
END OF SESSION 26
 
SESSION 27 SCHEDULE
Friday
SESSION 27: PROGRESS IN VENOUS DISEASE AND ITS TREATMENT - PART I (5-MINUTE TALKS)
Moderators: / TBD
x
3:36 PM - 3:42 PM Open Surgical Large Vein Reconstruction: Does It Have A Role In The Era Of Endovenous Stenting?
 
3:43 PM - 3:48 PM The Monocusp Venous Valve: An Autologous Solution To Valvular Incompetence: Technique And Results
 
3:49 PM - 3:54 PM Use Of PTA And Stents After Thrombosis Of The IVC Following IVC Filter Placement: Does It Work And What Happens To The Filter?
 
3:55 PM - 4:00 AM Ultrasound Bedside Placement Of Removable IVC Filter (CELECT) In Trauma Patients
 
4:01 PM - 4:06 PM Diagnosis And Treatment Of The Nutcracker Syndrome Or Mesoaortic Compression Of The Left Renal Vein: Is It Best Treated With Stents, Coil Embolization Or Reimplantation?
 
4:07 PM - 4:12 PM What’s New About The Recent ACCP Guidelines For The Treatment Of DVT: Why Did They Change?
 
4:13 PM - 4:19 PM Panel Discussion
Moderator(s): TBD / TBD  
4:19 PM - 4:24 PM Current Optimal Treatment For Ileofemoral DVT: How Best To Remove Clot?
 
4:25 PM - 4:30 PM New Developments In The Endovascular Treatment Of Venous And Arterial Trauma
 
4:31 PM - 4:36 PM With All These New Gadgets What Is The Best Method To Get Rid Of Clot With DVT?
 
4:37 PM - 4:42 PM Oral Contraceptive Use Can Cause Ileofemoral DVT In Women With Previously Undiagnosed May-Thurner Syndrome: How Should This Be Diagnosed And Treated?
 
4:43 PM - 4:49 PM Exciting New Developments In The Treatment Of Venous Disease From Around The World: Including Results From The JUPITER Trial Showing That Maintenance Statins Sharply Decrease The Incidence Of Venous Thromboembolism In Patients With Elevated CRP
 
4:50 PM - 4:55 PM Future Directions In Venous Disease Research And Treatment
 
4:56 PM - 5:03 PM Panel Discussion
END OF SESSION 27
 
SESSION 28 SCHEDULE
Friday
SESSION 28: PROGRESS IN VENOUS DISEASE – PART II (5-MINUTE TALKS)
Moderators: / TBD
x
5:03 PM - 5:08 PM New Techniques For Treating Complicated DVT
 
5:09 PM - 5:14 PM Aggressive Interventional Treatment Of Chronic DVT: A New Method To Decrease The Symptoms Of The Post-Thrombotic Syndrome: Techniques And Early Results
 
5:15 PM - 5:20 PM Modern Treatment Of Central Large Vein Stenosis: To Stent Or Not To Stent
 
5:21 PM - 5:26 PM What Is The Best Current Treatment For Proximal Long Saphenous Vein Thrombophlebitis?
 
5:27 PM - 5:32 PM All Venous Ulcers Are The Same: So Why Should We Bother To Differentiate Between Primary And Secondary (Post-Thrombotic) Venous Disease?
 
5:33 PM - 5:38 PM Importance Of The Location Of Infrapopliteal DVT In The Incidence Of Pulmonary Emboli
 
5:39 PM - 5:45 PM Panel Discussion
Moderator(s): TBD / TBD  
5:45 PM - 5:50 PM Use Of The ROTAREX Endovascular Mechanical Embolectomy Device For Treating Massive Pulmonary Emboli
 
5:51 PM - 5:56 PM What Is Necessary In A Venous Stent?
 
5:57 PM - 6:02 PM Acute DVT And Phlegmasia Cerulea Dolens In Children: Etiology And Treatment
 
6:03 PM - 6:08 PM Current Optimal Strategies And Techniques For Treating AV Malformations
 
6:09 PM - 6:14 PM Catheter Associated Upper Extremity DVT: Rates Of Progression, PE Potential, And Optimal Treatment
 
6:15 PM - 6:25 PM Panel Discussion
END OF SESSION 28
 
SESSION 29 SCHEDULE
Saturday
SESSION 29: NEW DEVELOPMENTS IN THE TREATMENT OF AAAS: EVAR, OPEN REPAIR, LAPAROSCOPIC AND ROBOTIC REPAIR (5-MINUTE TALKS)
Moderators: / TBD
x
6:40 AM - 6:45 AM State-of-the-Art In Protecting Renal Function With Angiographic Procedures That Require Contrast
 
6:46 AM - 6:51 AM Endovascular Repair Of Mycotic Aneurysms: Should It Be First-Line Therapy?
 
6:52 AM - 6:57 AM Tips And Tricks For Doing Hybrid Procedures For Thoracoabdominal Aneurysms Successfully And With Less Morbidity
 
6:58 AM - 7:03 AM Off-the-Shelf Balloon Expandable Stent-Graft Can Replace Many Fenestrated Grafts With Juxtarenal AAAs And Others With “Impossible Necks”
  Presenters(s):Ralf R. Kolvenbach, MD  
7:04 AM - 7:09 AM Changes In Patient Fitness And EVAR Suitability During Surveillance Of Small AAAs: When Should Small AAAs Have Early Repair?
 
7:10 AM - 7:15 AM Results From The PIVOTAL Trial Comparing Observation And EVAR For Small AAAs
 
7:16 AM - 7:21 AM Results From The CAESAR Trial Comparing Observation With EVAR For Small AAAs
 
7:22 AM - 7:31 AM Panel Discussion
Moderator(s): TBD / TBD  
7:31 AM - 7:41 AM What Are The Limits Of Laparoscopic AAA Repair: When Is It Superior To EVAR: Is It Applicable To Juxta- And Pararenal AAAs? (10-Minute Talk)
 
7:42 AM - 7:47 AM Robotic Aortic Surgery: What Is Needed To Make It Work And What Is Its Future In The Endovascular Era?
 
7:48 AM - 7:53 AM Standard Open Repair Is Still The Preferred Treatment For AAA In Good And Moderate Risk Patients
 
7:54 AM - 7:59 AM Glasgow Aneurysm Score For Risk Estimation With Ruptured AAAs: What Is It And Is It Valid In The Endovascular Era: Is There A Better Method?
 
8:00 AM - 8:05 AM Debate 16: We Must Have A Trial With Ruptured AAAs Comparing Treatment With CT And EVAR When Possible To Open Repair (OR)
 
8:06 AM - 8:11 AM Debate 16: We Don’t Need A Randomized Trial Comparing OR And EVAR: If Done Right EVAR Is Clearly Better
 
8:12 AM - 8:17 AM Updated (2009) World Experience With EVAR For Ruptured AAAs: The Case That EVAR Is Better If The Anatomy Is Favorable
 
8:18 AM - 8:26 AM Panel Discussion
END OF SESSION 29
 
SESSION 30 SCHEDULE
Saturday
SESSION 30: PROGRESS IN DISEASES OF THE AORTA AND ITS ABDOMINAL BRANCHES (5-MINUTE TALKS)
Moderators: / TBD
x
8:26 AM - 8:31 AM Present Status Of Renal Stenting: Results Of Randomized Comparisons Of Bare Metal Stents With Drug Eluting Stents (DES) And Best Medical Therapy: The Present Role Of Therapeutic Stenting And Prophylactic Stenting
 
8:32 AM - 8:37 AM Role Of Statins In Renal Artery Stenosis: What Is The Current Role For Renal Stenting And Embolic Protection?
 
8:38 AM - 8:43 AM Will Improved Renal Stenting Systems (Lower Profile, Rapid Exchange, DES, etc.) Make A Difference In Outcomes?
 
8:44 AM - 8:49 AM Renal Artery Stenting Under Embolic Protection With The FIBERNET Filter Device
 
8:50 AM - 8:55 AM Left Retroperitoneal Approach For Right Renal Artery Bypass
 
8:56 AM - 9:01 AM Treatment Of Renal Artery Aneurysms: Open Operation, Endovascular Treatments, Observation: When, How, Techniques And Tools
 
9:02 AM - 9:07 AM Panel Discussion
Moderator(s): TBD / TBD  
9:08 AM - 9:13 AM Current Treatment For Mid-Aortic Pararenal Coarctation: Is There A Role For Endovascular Treatment?
 
9:14 AM - 9:19 AM Is PTA And Stenting Safe For Classic Descending Aortic Coarctation: What Precautions Must Be Taken To Assure Safety: Is Open Surgery Ever Needed?
  Presenters(s):Christoph A. Nienaber, MD, PhD  
9:20 AM - 9:25 AM Stenting For Aortic Bifurcation Disease: Hugging Is Better Than Kissing
 
9:26 AM - 9:31 AM Technical Tips And Tricks For Visceral Artery Stenting
 
9:32 AM - 9:37 AM Treatment Of Visceral Artery Occlusive Disease: Are The Days Of Open Surgery Over?
 
9:38 AM - 9:43 AM Indications And Optimal Treatment For Visceral Artery Aneurysms: Lessons Learned From 200 Cases
 
9:44 AM - 9:52 AM Panel Discussion
END OF SESSION 30
 
SESSION 31 SCHEDULE
Saturday
SESSION 31: THE FUTURE, ISSUES, CONCEPTS AND INTERACTION WITH GOVERNMENT (5-MINUTE TALKS)
Moderators: / TBD
x
9:52 AM - 9:57 AM A Look To The Future Of Vascular Disease Treatment
  Presenters(s):Edward B. Diethrich, MD  
9:58 AM - 10:03 AM New Products For Improved Endografting From Cook: Is There Anything For Type A Aortic Dissection?
  Presenters(s):Matt M. Thompson, MD  
10:04 AM - 10:09 AM Next Generation Devices For TEVAR: What’s In The Pipeline?
 
10:10 AM - 10:15 AM Why Are Drug Eluting Balloons Going To Work?
 
10:16 AM - 10:21 AM Burning Bridges With Endovascular Treatment: Does Aggressive Endovascular Therapy Lead To More Costly And Inferior Results For Some Patients: How Can We Be More Selective?
 
10:22 AM - 10:27 AM Increasing Mortality With Decreasing Number Of Patients Treated In A Given Hospital: Should There Be More Regionalization: Will It Decrease Costs?
 
10:28 AM - 10:33 AM Debate 17: Regulatory Procedures Are Necessary To Protect Patient Safety Even If They Inhibit Innovation Somewhat: The Status Quo In The U.S. Is Good
 
10:34 AM - 10:39 AM Debate 17: Regulatory Procedures Inhibit Innovation Greatly And The Status Quo With Them In The U.S. Is Bad
 
10:40 AM - 10:45 AM What Will Be The Toll Of U.S. Government Actions On The Device Industry And The Economy: Will We Outsource This Industry Too?
 
10:46 AM - 10:52 AM Panel Discussion
END OF SESSION 31
 
SESSION 32 SCHEDULE
Saturday
SESSION 32: A TRIBUTE TO OUR MILITARY (5-MINUTE TALKS)
Moderators: / TBD
x
10:52 AM - 10:54 AM Introduction
 
10:55 AM - 11:00 AM Volunteer Vascular Surgery Program At Landstuhl Medical Center In Germany: A Civilian Perspective On Military Injuries
 
11:01 AM - 11:06 AM Use Of Prosthetic Grafts In Complex Vascular Trauma: An Altered New Limb Salvage Strategy For Patients With Limited Autologous Conduit
 
11:07 AM - 11:12 AM Surgical Response To Multiple Casualty Incidents From Single Explosive Events: Guidelines In The Modern Era
 
11:12 AM - 11:15 AM Questions And Answers
END OF SESSION 32
 
SESSION 33 SCHEDULE
Saturday
SESSION 33: ISSUES RELATED TO BUSINESS, COSTS, SPECIALTY AND TRAINING (5-MINUTE TALKS)
Moderators: / TBD
x
11:15 AM - 11:20 AM New Coding And Reimbursement Issues And Tips For 2009 And 2010
 
11:21 AM - 11:26 AM What Impact Will Health Care Reform Have On Vascular Surgery This Year And Next?
 
11:27 AM - 11:32 AM What Changes And Improvements Are Happening With The JVS In 2009 And Beyond?
 
11:33 AM - 11:38 AM Cost Savings From A Duplex Only Strategy For EVAR Surveillance After The 30-Day CT Scan
 
11:39 AM - 11:44 AM Improved System For Simulator Based Training In A Simulated Hybrid Operating Room
 
11:45 AM - 11:50 AM How To Get Medical Students To Go Into A 0 And 5 Vascular Surgery Training Program
 
11:51 AM - 11:56 AM Vascular Surgery Training Now And In The Future
 
11:57 AM - 12:02 PM Ideal Training Program In Vascular Surgery: Does It Need General Surgery?
 
12:03 PM - 12:09 PM Panel Discussion
END OF SESSION 33
 
SESSION 34 SCHEDULE
Saturday
SESSION 34: LUNCHEON SESSION ON NEW AND IMPROVED TECHNQUES, ENDOGRAFTS AND DEVICES (5-MINUTE TALKS)
Moderators: / Matt M. Thompson, MD
x
12:10 PM - 12:15 PM Update On The ANACONDA Graft For EVAR: Advantages And Limitations
 
12:16 PM - 12:21 PM Status Of The ENDURANT AAA Stent-Graft In The U.S.
 
12:22 PM - 12:27 PM The EVITA Graft For EVAR: Advantages And Limitations
 
12:28 PM - 12:33 PM U.S. Experience With The AORFIX Endograft: (Lombard Medical): Advantages, Limitations And Status Of The U.S. Trial
 
12:34 PM - 12:39 PM Advantages, Limitations And Experience With The RELAY PLUS Thoracic Endograft (Bolton Medical)
 
12:40 PM - 12:45 PM Update On The Status Of The U.S. Trial With The APTUS Endograft With Staple Fixation: Advantages, Technique And Limitations
 
12:46 PM - 12:51 PM Update On The Improved POWERLINK Endograft With IntuiTrak From Endologix With The IntuiTrak Express Delivery System For Easier Deployment: How Does It Work; Advantages; Limitations
 
12:52 PM - 12:57 PM The Ever Shrinking Profile Of Devices For EVAR: When Does It Matter? The New ZENITH Low Profile Device From Cook
 
12:58 PM - 1:03 PM Are New And Better Stents Possible: By What Approaches?
 
1:04 PM - 1:10 PM Panel Discussion
END OF SESSION 34
 
SESSION 35 SCHEDULE
Saturday
SESSION 35: ETHICS, STANDARDS, REGISTRIES, RELATIONS WITH INDUSTRY, MALPRACTICE ISSUES (5-MINUTE TALKS)
Moderators: / TBD
x
1:10 PM - 1:15 PM What Is Happening To The Relationship Between Physicians, Industry And CME: Is Government And The ACCME Going To Block Industry Support For CME Activities?
 
1:16 PM - 1:21 PM Debate 18: Off-Label Use Of Devices By Physicians Is Acceptable: It Facilitates Patient Treatment
 
1:22 PM - 1:27 PM Debate 18: Off-Label Use Of Devices Is Not Acceptable In Most Instances: Reasons Why
 
1:28 PM - 1:33 PM Little Known Risks Of Hospital Or Institutional Malpractice Insurance Coverage
 
1:34 PM - 1:39 PM Randomized Controlled Trials With Patient Groups Or Arms Getting No Treatment Or Observation Are Inherently Flawed: Why And What Can Be Done About It?
 
1:40 PM - 1:45 PM Should We Have Reporting Standards For Endovascular Interventions: How Will We Get Them?
 
1:46 PM - 1:51 PM Evolution Of The Northern New England Vascular Registry: New Information Regarding AAA Repair And Carotid Endarterectomy
 
1:52 PM - 2:00 PM Panel Discussion
END OF SESSION 35
 
SESSION 36 SCHEDULE
Saturday
SESSION 36: VASCULAR DISEASE NATURAL HISTORY, MEDICAL TREATMENTS AND PREVENTION, AND TREATMENT OF COMPLICATIONS (5-MINUTE TALKS)
Moderators: / TBD
x
2:00 PM - 2:05 PM Long-Term Cardiac Outcomes Of High Risk AAA Patients After EVAR And OR
 
2:06 PM - 2:11 PM Does The Presence Of An AAA Protect Against Stroke: Why Is This So?
 
2:12 PM - 2:17 PM Hybrid Technique To Treat Infected Vascular Grafts With An Endograft, Drainage And A VAC Dressing: When Can They Work?
 
2:18 PM - 2:23 PM Pharmacologic Approaches To Spinal Cord Protection
 
2:24 PM - 2:29 PM What Technical Maneuvers Can Help The CAS Operator Deal With Inability To Retrieve Filters, No Flow Through The Filter, Heavily Calcified Lesions And Intolerance To Flow Arrest
 
2:30 PM - 2:35 PM Innovative Endovascular Treatments Of Complex Failures Of Previous EVAR Procedures: These Bailouts Include Use Of Fenestrated Cuffs
 
2:36 PM - 2:41 PM Tips And Tricks To Allow Endovascular Treatment Of Complex Limb Disconnects After EVAR
 
2:42 PM - 2:47 PM Iron Stores, Inflammation And Biomarkers: How Do They Influence Atherosclerosis: Do Statins Help?
 
2:48 PM - 2:53 PM Technical Tips On The Use Of ONYX In The Treatment Of Type II Endoleaks
 
2:54 PM - 3:08 PM Panel Discussion
END OF SESSION 36
 
SESSION 37 SCHEDULE
Saturday
SESSION 37: UPDATES AND NEW TECHNIQUES (4-MINUTE FAST-PACED TALKS)
Moderators: / TBD
x
3:08 PM - 3:12 PM How To Predict AAA Rupture By Looking At Wall Stress, Wall Strength And Extent Of Intraluminal Thrombus
 
3:13 PM - 3:17 PM With TEVAR What Is The Best Way To Decrease Flow And Minimize Migration During Deployment: The Myth Of Lowering BP For Deployment Of Thoracic Endografts
 
3:18 PM - 3:22 PM Exceptional Way To Treat Infected Aneurysmal Sac Due To Aorto-Esophageal Fistula
 
3:23 PM - 3:27 PM What Is The Role Of A Flexible Kink-Resistant Stent-Graft:7-Year Clinial Experience With The AORFIX Aortic Endograft For AAAs
 
3:28 PM - 3:32 PM Debate 19: No Patient Should Undergo CAS Without Embolic Protection
 
3:33 PM - 3:37 PM Debate 19: There Are Patients Who Should Undergo CAS Without Embolic Protection
 
3:38 PM - 3:42 PM The FDA's Current Position On Embolic Protection Devices During CAS
 
3:43 PM - 3:47 PM New Simplified Sutureless Device For End-to-Side Aortic Anastomoses
 
3:48 PM - 3:52 PM The Un-Balloon Non-Occlusive Modeling Catheter: A Better Answer To Aortic Stent-Graft Forced Expansion For Modeling
 
3:53 PM - 3:57 PM How Best To Revascularize Occluded Mesenteric Artery: When Is PTA And Stenting Safe, And When Is Open Surgery Best Based On A Large Clinical Experience?
 
3:58 PM - 4:04 PM Panel Discussion
Moderator(s): TBD / TBD  
4:04 PM - 4:08 PM How To Create A Hybrid Operating Room
 
4:09 PM - 4:13 PM Optimal Sequence And Staging For Patients Who Need Coronary And Carotid Procedures (CAS or CEA)
 
4:14 PM - 4:18 PM When Is Laparoscopic Treatment Of Type II Endoleaks Required: What Are The Technical Requirements: How Much Laparoscopic Experience Is Needed?
 
4:19 PM - 4:23 PM Celiac Artery Coverage During TEVAR Is Safe Acutely And Midterm: When Should It Be Avoided?
 
4:24 PM - 4:28 PM Errors In Determining AAA Diameter With Ultrasound Compared To 3-D CTA: Its Importance In Evaluating The ADAM And UK Small Aneurysm Trials
  Presenters(s):Timothy A. Resch, MD, PhD  
4:29 PM - 4:33 PM Do TEVAR Outcomes Differ For Acute And Chronic Type B Aortic Dissections And Why?
 
4:34 PM - 4:38 PM Indications For Statin In Patients Undergoing EVAR: When Should They Be Started And At What Dose?
 
4:39 PM - 4:43 PM Debate 20: Failed Endografts Requiring Open Surgery Usually Mandate Graft Removal: Tips For Doing This Safely
 
4:44 PM - 4:48 PM Debate 20: Open Surgical Salvage Of Failed Endograft Without Graft Removal Is Usually Possible: Technical Tips For Accomplishing This
 
4:49 PM - 4:55 PM Panel Discussion
END OF SESSION 37
 
SESSION 38 SCHEDULE
Saturday
SESSION 38: MORE UPDATES AND NEW TECHNIQUES (5-MINUTE TALKS)
Moderators: / TBD
x
4:55 PM - 5:00 PM Adverse Event Rates For CAS And CEA From The SVS Registry
 
5:01 PM - 5:06 PM Tips And Tricks For Anterior Exposure Of The Spine By Vascular Surgeons
 
5:07 PM - 5:12 PM Diagnosis And Treatment Of Arterial Aneurysms In Patients With Behçet Disease
 
5:13 PM - 5:18 PM Duplex Velocities Determine Need For CAS After CEA With Neurological Symptoms; Without Symptoms
 
5:19 PM - 5:24 PM Men And Women With AAAs Behave Differently And Different Guidelines Are Needed
 
5:25 PM - 5:30 PM 3-D CT Localization Of Artery Of Adamkiewitz: Is It Accurate?
 
5:31 PM - 5:36 PM Role Of Endovascular Techniques In Treatment Of Carotid Body Tumors
 
5:37 PM - 5:43 PM Panel Discussion
Moderator(s): TBD / TBD  
5:43 PM - 5:48 PM The Bridge Graft With Vein And PTFE: A New Option For CLI With 15 Years Follow-up Showing Endothelialization Of The PTFE
 
5:49 PM - 5:54 PM Tips And Tricks For Intracranial Neuro Rescue During And After CAS
 
5:55 PM - 6:00 PM Simple Method To Measure Trans-Stenotic Pressure Gradient Accurately
 
6:01 PM - 6:06 PM How To Cool The Kidneys To Protect Them During Open Pararenal Aortic Surgery
 
6:07 PM - 6:12 PM Use Of Amplatz Septal Occluder For Gunshot Wound Of The Aorta
 
6:13 PM - 6:18 PM Advantages Of The TAArget Endograft For TEVAR: 3-Year Experience At A Single Center
 
6:19 PM - 6:25 PM Panel Discussion
END OF SESSION 38
 
SESSION 39 SCHEDULE
Sunday
SESSION 39: NEW DEVELOPMENTS, TECHNIQUES AND CONCEPTS (5-MINUTE TALKS)
Moderators: / TBD
x
6:45 AM - 6:50 AM What Proportion Of AAAs Can Be Treated With Current Endografts?
 
6:51 AM - 6:56 AM Use Of Duplex Imaging To Detect Common Femoral Artery Injuries During EVAR
 
6:57 AM - 7:02 AM Tips And Tricks In The Endovascular Treatment Of Large A-V Fistulas
 
7:03 AM - 7:08 AM Virtual Angioscopy Of The Thoracic And Abdominal Aorta: Is It A Useful Tool Or A Fancy Toy?
 
7:09 AM - 7:14 AM Tips And Tricks To Make TIPS Procedures Effective Using Stent-Grafts
 
7:15 AM - 7:20 AM How To Use Clopidigrel (Plavix) To Make CEA Safer
 
7:21 AM - 7:26 AM Panel Discussion
Moderator(s): TBD / TBD  
7:26 AM - 7:31 AM Myths And Little Known Facts About Collateral Development With Major Arterial Occlusion
 
7:32 AM - 7:37 AM Minimally Invasive Approach To Treat The Median Arcuate Ligament Syndrome: Technique And Results
 
7:38 AM - 7:43 AM Chronic Lymphedema: How Best To Treat It: Are There Still Surgical Options?
 
7:44 AM - 7:49 AM Technical Tips For Crossing Long Tibial Occlusions
 
7:50 AM - 7:55 AM Are Reentry Devices Necessary When Crossing Most Long Totally Occluded Segments?
 
7:56 AM - 8:01 AM New Developments And Updated Results With Duplex Guided PTA And Stenting
 
8:02 AM - 8:08 AM Panel Discussion
END OF SESSION 39
 
SESSION 40 SCHEDULE
Sunday
SESSION 40: MORE ABOUT THORACIC AND ABDOMINAL ANEURYSMS (5-MINUTE TALKS)
Moderators: / TBD
x
8:08 AM - 8:13 AM 10-Year Results After EVAR vs. 10-Year Results After Open Repair
 
8:14 AM - 8:19 AM Updated Data On Safety Of Bilateral Hypogastric Interruption With EVAR And OR: Cooperative Study In 135 Patients
 
8:20 AM - 8:25 AM Endovascular Treatment Of Iliac Aneurysms Involving The Hypogastric Artery: Concurrent Comparison Of Branched Endografts vs. Hypogastric Occlusion
 
8:26 AM - 8:31 AM Significance Of Mesenteric Arteries During EVAR
 
8:32 AM - 8:37 AM Debate 21: With EVAR Outcomes Are Not Influenced By AAA Size
 
8:38 AM - 8:43 AM Debate 21: With EVAR Outcomes Are Influenced By Size: Big Is Bad
 
8:44 AM - 8:49 AM Can Positron Emission Tomography (PET) Imaging And Biochemical Analysis Help To Predict AAA Rupture?
 
8:50 AM - 8:56 AM Panel Discussion
Moderator(s): TBD / TBD  
8:56 AM - 9:01 AM Technique For Fascial Suture To Close Puncture Sites For Percutaneously Placed Large Sheaths: It Works But It Has To Be Done Right (Video Presentation)
 
9:02 AM - 9:07 AM Tips And Tricks For Improving Results Or Managing Tortuous Or Adverse Neck Anatomy With The Gore Excluder Graft
 
9:08 AM - 9:13 AM New Developments In The Management Of Graft Enteric (Aortoduodenal) Fistulas: Successful In Situ Repair With Silver Impregnated, Rifampin Soaked Grafts
 
9:14 AM - 9:19 AM Advantages And Limitations Of The New Medtronic Valiant Captivia Stent-Graft For TEVAR
  Presenters(s):Matt M. Thompson, MD  
9:20 AM - 9:25 AM Adjuvant Maneuvers To Affect Graft Tilt During EVAR With Angulated Necks: Should We Try To Fit The Aorta To The Graft Or Should We Try To Fit The Graft To The Aorta – And How?
 
9:26 AM - 9:31 AM Off-The-Shelf Device For EVAR Treatment Of Juxtarenal Aneurysms
 
9:32 AM - 9:38 AM Panel Discussion
END OF SESSION 40
 
SESSION 41 SCHEDULE
Sunday
SESSION 41: NEW DEVELOPMENTS IN DISEASES OF THE CAROTIDS, VERTEBRALS AND SUPRA-AORTIC TRUNKS (5-MINUTE TALKS)
Moderators: / TBD
x
9:38 AM - 9:43 AM Debate 22: Covered Stents Are Good For The Treatment Of Carotid Artery Aneurysms
 
9:44 AM - 9:49 AM Debate 22: Endovascular Repair Of Extracranial Carotid Aneurysms Is Still A Hazardous Procedure
 
9:50 AM - 9:55 AM Mortality And Cost Implications For Delaying Treatment After A TIA Or Small Stroke Are Serious: How To Facilitate Early Treatment: The EXPRESS Trial
 
9:56 AM - 10:01 AM Determinants And Late Clinical Significance Of Microemboli With CAS And CEA: When Do They Matter?
 
10:02 AM - 10:07 AM Dos And Don’ts Of Endovascular Management Of Carotid Trauma
 
10:07 AM - 10:20 AM Panel Discussion
Moderator(s): TBD / TBD  
10:20 AM - 10:25 AM Routine Shunting vs. Selective Shunting In CEA Based On Stump Pressure: Which Is Best Based On A Randomized Controlled Trial?
 
10:26 AM - 10:31 AM New Portable Multisensor Transducer For Carotid Screening By Non-Specialized Office Personnel
 
10:32 AM - 10:37 AM Update On Population Based Studies Comparing Adverse Event Rates With CAS And CEA In The U.S.: Are CAS Results Improving?
 
10:38 AM - 10:43 AM Diagnosis And Treatment Of Vulnerable Carotid Plaques Causing TIAs Or Strokes: When Should They Be Treated By CEA Or By CAS?
 
10:44 AM - 10:49 AM Tips And Tricks For The Endovascular Treatment Of Subclavian And Innominate Stenosis
 
10:50 AM - 10:55 AM Update On Treatment Of Acute Stroke By IV Thrombolysis And CEA: Why CEA Not CAS: Advantages And Limitations
 
10:56 AM - 11:03 AM Panel Discussion
END OF SESSION 41
 
SESSION 42 SCHEDULE
Sunday
SESSION 42: NEW DEVELOPMENTS IN CAS (4-MINUTE FAST PACED TALKS)
Moderators: / TBD
x
11:03 AM - 11:07 AM What The Trial And Registry Results To Date Tell Us About The Present Status Of CAS: What Are The Prospects For A Change In This Status In The Future?
 
11:08 AM - 11:12 AM How To Lower Risk Of CAS In Octogenerians And Other High Risk Patients
 
11:13 AM - 11:17 AM Combined Carotid And Coronary Procedures: Nationwide Statistics Show That CAS Has Lower Adverse Events Rates Than CEA
 
11:18 AM - 11:22 AM CAS Experience With Endovascular Flow Interruption Using The MOMA Device: Advantages And Limitations
 
11:23 AM - 11:27 AM Use Of IVUS As An Important Quality Control Technique For CAS: Are There Risks To Its Use?
 
11:28 AM - 11:32 AM Debate 23: Screening To Detect Asymptomatic Carotid Stenosis Is Worthwhile So It Can Be Treated By CAS Or CEA
 
11:33 AM - 11:37 AM Debate 23: Screening To Detect Asymptomatic Carotid Stenosis Is A Bad Thing To Do Except As A Way To Get Patients On Statins: CAS Or CEA In Asymptomatic Patients Consumes Resources But Does Little To Prevent Stroke
 
11:38 AM - 11:42 AM Carotid Interventions For Stroke In Evolution: Indications, Techniques And Results: A 5-Year Experience
 
11:43 AM - 11:47 AM CAS Setbacks: The Plan Was Flawed From The Beginning: Will CAS Recover?
 
11:48 AM - 11:52 AM Carotid Stenting For Radiation Arteritis Has A High Complication And Restenosis Rate
 
11:53 AM - 11:59 AM Panel Discussion
Moderator(s): TBD / TBD  
11:59 AM - 12:03 PM Clinical Course Of Asymptomatic Carotid Stenosis With End-Diastolic Velocity 100-125 cm/sec: Stent Or Observe?
 
12:04 PM - 12:08 PM Technique Of Using An Interruption Of Flow Embolic Protection Device (MOMA) To Make CAS Safer
 
12:09 PM - 12:13 PM How To Identify Stroke Threatening Plaques In Asymptomatic Patients By Contrast Duplex Or Biochemical Markers (Alpha NT pro BNP)
 
12:14 PM - 12:18 PM The Value Of Pre-Procedure CTA To Improve The Outcomes Of CAS
 
12:19 PM - 12:23 PM Restenosis After CAS Is Equal To That After CEA Based On Long-Term Results In 1,000 Patients
 
12:24 PM - 12:28 PM Transcervical CAS With Flow Reversal Eliminates Emboli During CAS: Why Does It Work And What Are The Adverse Event Rates With This Approach?
 
12:29 PM - 12:33 PM Outcomes After CEA: Is There A High Risk Population And Does This Have A Bearing On Some Of The CAS Trials Such As SAPPHIRE?
  Presenters(s):Richard P. Cambria, MD  
12:34 PM - 12:45 PM Panel Discussion
Refreshments Available
END OF SESSION 42
 
SESSION 43 SCHEDULE
Sunday
SESSION 43: NEW CONCEPTS, ADVANCES, LATE BREAKING INFORMATION (5-MINUTE TALKS)
Moderators: / TBD
x
12:45 PM - 12:50 PM Debate 24: Transcranial Doppler During CAS: When And Why Is Flow Reversal With The Gore-Parodi Device Better?
 
12:51 PM - 12:56 PM Debate 24: Why Flow Cessation During CAS (With The MOMA Device) Is Better: The ARMOUR Trial
 
12:57 PM - 1:02 PM Update On Results From The ACT Trial Comparing CEA And CAS With Protection In Asymptomatic Patients With Carotid Stenosis
 
1:03 PM - 1:08 PM Tips And Tricks To Allow Large Sheath Access For TEVAR And EVAR: Alternatives To External Conduits When Iliac Arteries Are Too Small Or Diseased To Allow Femoral Access
 
1:09 PM - 1:14 PM Noninvasive Treatment For CLI With A Sequential Compression Device: Does It Work?
 
1:15 PM - 1:20 PM What Are The Results And Complications With The TAG Endograft When It Is Used More Widely And Not Only In Centers Of Excellence (The Post Marketing Approval Trial)?
 
1:21 PM - 1:26 PM Treatment Of Iliac Aneurysms By Off-Label Modified Use Of Reversed ZENITH Limb Extensions: Technical Tips
 
1:27 PM - 1:32 PM What Is The Value Of C-Arm CT Scanning In EVAR Procedures And Patients?
  Presenters(s):Matt M. Thompson, MD  
1:33 PM - 1:38 PM The NELLIX Sac Anchoring Endoprosthesis For AAA Exclusion: A New Concept For EVAR
 
1:39 PM - 1:44 PM Advantages To 3-D Imaging (With M2S, TeraRecon, Or 3-Mensio) In Planning For Standard Infrarenal EVAR Procedures
 
1:45 PM - 1:53 PM Panel Discussion
END OF SESSION 43
 
SESSION 44 SCHEDULE
Sunday
SESSION 44: NEW CONCEPTS, ADVANCES AND LATE BREAKING INFORMATION (5-MINUTE TALKS)
Moderators: / TBD
x
1:53 PM - 1:58 PM New Developments In The Treatment Of Fibromuscular Dysplasia
 
1:59 PM - 2:04 PM When To Stent Renal Artery Stenosis With EVAR And What To Do For Restenosis
 
2:05 PM - 2:10 PM HYPERMED Camera For Measuring Cutaneous O2 Saturation Before And After Intervention: How Does It Help?
 
2:11 PM - 2:16 PM Cutting Balloon Facilitates CAS With Very Calcified Plaques: What Are The Dangers?
 
2:17 PM - 2:22 PM CAS Is Appropriate In Asymptomatic Patients But Not In Symptomatic Patients: CMS Has It Wrong
 
2:23 PM - 2:28 PM Endografts Can Serve As A Bridge To Definitive Repair: When And How Can This Be Helpful?
 
2:29 PM - 2:34 PM Lower Extremity Arterial Flow Is Decreased In Patients With Venous Disease: Why Does It Matter?
 
2:35 PM - 2:40 PM EVAR Without Contrast Is Safe: How To Do It
 
2:41 PM - 2:46 PM Covered Stents Will Improve Treatment For Renal Artery Stenosis
 
2:47 PM - 2:52 PM Cerebral Hyperfusion Syndrome Is Not What You Think: We Have Been Misled
 
2:53 PM - 3:00 PM Panel Discussion
3:00 PM - 3:05 PM Raffle Prize Drawing for fully paid, clinician attendees. You must be present to win.
3:05 PM - 3:05 PM Symposium Ends
END OF SESSION 44